Technical Analysis for GALT - Galectin Therapeutics Inc.

Grade Last Price % Change Price Change
grade F 4.01 -5.65% -0.24
GALT closed down 5.65 percent on Thursday, May 23, 2019, on 2.75 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical GALT trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Stochastic Reached Oversold Weakness 0.00%
Outside Day Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Signal Line Cross Bearish -5.65%
Fell Below 20 DMA Bearish -11.28%
Fell Below 50 DMA Bearish -11.28%

Older signals for GALT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Galectin Therapeutics Inc., a development stage company, engages in the development of therapies for cancer and fibrotic disease. Its lead product candidates include GR-MD-02, a complex polysaccharide polymer for the treatment of liver fibrosis and fatty liver disease for which the company intends to initiate a Phase I clinical trial in patients with non-alcoholic steatohepatitis; and GM-CT-01, a linear polysaccharide polymer comprising mannose and galactose that is in a Phase I/II clinical trial in Europe as a combination therapy with a tumor vaccine in patients with advanced melanoma. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Cancer Tumor Hepatitis Therapies For Cancer Lectins Liver Fibrosis Non Alcoholic Fatty Liver Disease Steatohepatitis Europe Galectin Galectin 3
Is GALT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.49
52 Week Low 3.17
Average Volume 397,772
200-Day Moving Average 4.8449
50-Day Moving Average 4.6478
20-Day Moving Average 4.535
10-Day Moving Average 4.541
Average True Range 0.3261
ADX 10.96
+DI 15.1181
-DI 22.9412
Chandelier Exit (Long, 3 ATRs ) 4.0017
Chandelier Exit (Short, 3 ATRs ) 4.9683
Upper Bollinger Band 4.9343
Lower Bollinger Band 4.1357
Percent B (%b) -0.16
BandWidth 17.609702
MACD Line -0.0762
MACD Signal Line -0.0324
MACD Histogram -0.0437
Fundamentals Value
Market Cap 140.55 Million
Num Shares 35.1 Million
EPS -0.61
Price-to-Earnings (P/E) Ratio -6.57
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.87
Resistance 3 (R3) 4.96 4.76 4.73
Resistance 2 (R2) 4.76 4.54 4.72 4.68
Resistance 1 (R1) 4.39 4.41 4.29 4.30 4.63
Pivot Point 4.19 4.19 4.14 4.14 4.19
Support 1 (S1) 3.81 3.97 3.71 3.72 3.39
Support 2 (S2) 3.61 3.83 3.57 3.34
Support 3 (S3) 3.24 3.61 3.29
Support 4 (S4) 3.15